mSphereMicrobiologyPeer-reviewed journal article
Dietary xanthan gum alters antibiotic efficacy against the murine gut microbiota and attenuates Clostridioides difficile colonization
M. K. Schnizlein, K. C. Vendrov, S. J. Edwards, E. Martens, V. B. Young
Abstract
Dietary fiber provides a variety of microbiota-mediated benefits ranging from anti-inflammatory metabolites to pathogen colonization resistance. A healthy gut microbiota protects against Clostridioides difficile colonization. Manipulation of these microbes through diet may increase colonization resistance to improve clinical outcomes. The primary objective of this study was to identify how the dietary fiber xanthan gum affects the microbiota and C. difficile colonization.\n\nWe added 5% xanthan gum to the diet of C57Bl/6 mice and examined its effect on the microbiota through 16S rRNA-gene amplicon sequencing and short-chain fatty acid analysis. Following either cefoperazone or an antibiotic cocktail administration, we challenged mice with C. difficile and measured colonization by monitoring colony-forming units.\n\nXanthan gum administration associates with increases in fiber degrading taxa and short-chain fatty acid concentrations. However, by maintaining both the diversity and absolute abundance of the microbiota during antibiotic treatment, the protective effects of xanthan gum administration on the microbiota were more prominent than the enrichment of these fiber degrading taxa. As a result, mice that were on the xanthan gum diet experienced limited to no C. difficile colonization.\n\nXanthan gum administration alters mouse susceptibility to C. difficile colonization by maintaining the microbiota during antibiotic treatment. While antibiotic-xanthan gum interactions are not well understood, xanthan gum has previously been used to bind drugs and alter their pharmacokinetics. Thus, xanthan gum may alter the activity of the oral antibiotics used to make the microbiota susceptible. Future research should further characterize how this and other common dietary fibers interact with drugs.\n\nIMPORTANCEA healthy gut bacterial community benefits the host by breaking down dietary nutrients and protecting against pathogens. Clostridioides difficile capitalizes on the absence of this community to cause diarrhea and inflammation. Thus, a major clinical goal is to find ways to increase resistance to C. difficile colonization by either supplementing with bacteria that promote resistance or a diet to enrich for those already present in the gut. In this study, we describe an interaction between xanthan gum, a human dietary additive, and the microbiota resulting in an altered gut environment that is protective against C. difficile colonization.
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differences in Gut Microbiota Assembly Alter Its Ability to Metabolize Dietary Polysaccharides and Resist Clostridioides difficile Colonization
M. K. Schnizlein, A. K. Standke, … V. B. Young·bioRxiv·May 20, 2022
- The Food Additive Xanthan Gum Drives Adaptation of the Human Gut Microbiota
M. P. Ostrowski, S. Leanti La Rosa, … E. Martens·bioRxiv·Jun 2, 2021
- Clearance of Clostridioides difficile colonization is associated with antibiotic-specific bacterial changes
N. A. Lesniak, A. M. Schubert, … P. D. Schloss·bioRxiv·Nov 16, 2020
- Gnotobiotic OMM12 mice support sustained Clostridioides difficile colonization without antibiotic pretreatment
Devon E. Conti, Eva Chatonnat, … Julian R. Garneau·bioRxiv·Oct 28, 2026
- Mice colonized with the defined microbial community OMM19.1 are susceptible to C. difficile infection without prior antibiotic treatment.
Michelle J. Chua, James Collins·mSpherePeer-reviewed·Oct 29, 2024
- Intestinal inflammation reversibly alters the microbiota to drive susceptibility to Clostridioides difficile colonization in a mouse model of colitis
M. R. Barron, K. L. Sovacool, … V. B. Young·bioRxiv·Apr 7, 2022